1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmNot yet recruitingPhase 22026-10-02NCT07755202